Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Pub. Group Country of Publication: England NLM ID: 9808008 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-232X (Electronic) Linking ISSN: 14345161 NLM ISO Abbreviation: J Hum Genet Subsets: MEDLINE
    • Publication Information:
      Publication: 2009- : London : Nature Pub. Group
      Original Publication: Tokyo : Springer-Verlag, c1998-
    • Subject Terms:
    • Abstract:
      The genomic regions containing PNPLA3, SAMM50 and PARVB are susceptibility loci for the development and progression of nonalcoholic fatty liver disease (NAFLD). In order to search for all common variations in this region, we amplified the genomic DNA of 28 NAFLD patients by long-range PCR, covering the entire susceptibility region and sequenced the DNA using indexed multiplex next-generation sequencing. We found 329 variations, including four novel variations. Fine mapping of variations including insertion/deletions was performed for 540 NAFLD patients (488 with nonalcoholic steatohepatitis (NASH) and 52 with simple steatosis) and 1012 control subjects. HaploView analysis showed that linkage disequilibrium (LD) block 1 and 2 occurred in PNPLA3, block 3 in SAMM50 and block 4 in PARVB. Variations in LD blocks 1-4 were significantly associated with NAFLD as compared with control subjects (P<1 × 10(-8)). Variations in LD block 2 were significantly associated with the NAFLD activity score (NAS), aspartate aminotransferase and alanine aminotransferase. Variations in LD block 1 were significantly associated with the fibrosis stage. The strongest associations were observed for variations in LD block 4, with NASH as compared with simple steatosis (P=7.1 × 10(-6)) and NAS (P=3.4 × 10(-6)). Our results suggested that variations, including insertion/deletions, in PARVB, as well as those in PNPLA3, are important in the progression of NAFLD.
    • References:
      Mayo Clin Proc. 1980 Jul;55(7):434-8. (PMID: 7382552)
      PLoS Genet. 2011 Mar;7(3):e1001324. (PMID: 21423719)
      Hepatology. 2011 Jun;53(6):1883-94. (PMID: 21381068)
      Hepatology. 1995 Dec;22(6):1714-9. (PMID: 7489979)
      J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:153-62. (PMID: 21199527)
      J Hum Genet. 2001;46(8):471-7. (PMID: 11501945)
      Nat Genet. 2008 Dec;40(12):1461-5. (PMID: 18820647)
      Nat Biotechnol. 2011 Jan;29(1):24-6. (PMID: 21221095)
      PLoS One. 2012;7(6):e38322. (PMID: 22719876)
      Bioinformatics. 2009 Aug 15;25(16):2078-9. (PMID: 19505943)
      Hepatology. 2010 Sep;52(3):1134-42. (PMID: 20648554)
      Gastroenterology. 2010 Nov;139(5):1567-76, 1576.e1-6. (PMID: 20708005)
      Bioinformatics. 2009 Jul 15;25(14):1754-60. (PMID: 19451168)
      Hepatology. 2005 Jun;41(6):1313-21. (PMID: 15915461)
      Hum Genet. 2013 Jul;132(7):783-92. (PMID: 23535911)
      Mol Cell Biol. 2008 Jan;28(2):687-704. (PMID: 17998334)
      Gastroenterology. 2002 Nov;123(5):1705-25. (PMID: 12404245)
      J Biol Chem. 2004 Oct 1;279(40):41695-705. (PMID: 15284246)
      Genome Res. 2010 Sep;20(9):1297-303. (PMID: 20644199)
      N Engl J Med. 2002 Apr 18;346(16):1221-31. (PMID: 11961152)
      Hum Genet. 2012 Jul;131(7):1145-52. (PMID: 22258181)
      Int J Hepatol. 2012;2012:648915. (PMID: 22567408)
      Curr Diab Rep. 2008 Apr;8(2):156-63. (PMID: 18445359)
      Nucleic Acids Res. 2010 Sep;38(16):e164. (PMID: 20601685)
      J Gastroenterol Hepatol. 2003 Feb;18(2):124-38. (PMID: 12542595)
      BMC Med Genet. 2010 Dec 22;11:172. (PMID: 21176169)
      Hepatol Res. 2009 Oct;39(10):963-71. (PMID: 19624767)
      Gastroenterology. 1999 Jun;116(6):1413-9. (PMID: 10348825)
      J Cell Sci. 2010 Mar 1;123(Pt 5):747-55. (PMID: 20164304)
      Bioinformatics. 2005 Jan 15;21(2):263-5. (PMID: 15297300)
      J Gastroenterol. 2012 Mar;47(3):215-25. (PMID: 22310735)
      J Lipid Res. 2011 Feb;52(2):318-29. (PMID: 21068004)
      Am J Hum Genet. 2007 Sep;81(3):559-75. (PMID: 17701901)
      Liver Int. 2009 Aug;29(7):1078-85. (PMID: 19302184)
      BMC Gastroenterol. 2008 Jun 27;8:27. (PMID: 18588668)
      J Clin Invest. 2012 Nov;122(11):4130-44. (PMID: 23023705)
      Semin Liver Dis. 2001;21(1):3-16. (PMID: 11296695)
      Brief Bioinform. 2013 Mar;14(2):178-92. (PMID: 22517427)
    • Accession Number:
      0 (Membrane Proteins)
      0 (PARVB protein, human)
      11003-00-2 (Actinin)
      EC 3.1.1.3 (Lipase)
      EC 3.1.1.3 (adiponutrin, human)
    • Publication Date:
      Date Created: 20140314 Date Completed: 20150413 Latest Revision: 20211021
    • Publication Date:
      20240104
    • Accession Number:
      10.1038/jhg.2014.17
    • Accession Number:
      24621583